Glucotrack, Inc. Cash Flow Statement
GCTK|7 years of annual SEC 10-K data (FY2014-FY2020)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
Glucotrack, Inc. used $4M in operating cash flow and negative free cash flow of $4M in FY2020.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|
| Net Income | $3.5M | -$6.7M | $10.3M | -$5.8M | $3.0M | -$9.8M | -$2.8M |
| Depreciation & Amortization | $51.0K | $58.8K | $67.9K | $44.9K | $34.7K | $33.7K | $25.5K |
| Operating Cash Flow | -$3.9M | -$4.9M | -$5.9M | -$4.6M | -$3.4M | -$3.2M | -$2.3M |
| Capital Expenditures | $23.0K | $5.4K | $19.5K | $143.7K | $63.5K | $64.3K | $11.3K |
| Free Cash Flow | -$3.9M | -$4.9M | -$5.9M | -$4.7M | -$3.4M | -$3.3M | -$2.3M |
| FCF Margin | -1885.6% | -11262.1% | -1003.4% | -3289.1% | -5730.0% | -5490.6% | -3861.7% |